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Background/introduction
The U.S. Food and Drug Administration (FDA) has
automatically classified focused ultrasound (FUS) devices
Class III, which requires sponsors to demonstrate the
safety and effectiveness of a device through clinical
trials. This requirement adds significant time and cost
to the device development process; reclassification to
Class II would be highly beneficial for the future of FUS.
Methods
Statute outlines two strategies for reclassifying FUS to a
class with lower regulatory standards: filing a petition for
reclassification based on new information and filing a de
novo application to request a risk-based review of a novel
technology.
Results and conclusions
There are three additional options for Focused Ultra-
sound Foundation action with less direct effects on
reclassification: creating grants for regulatory science,
educating stakeholders about FDA, and increasing
direct-to-FDA advocacy. In this paper, each of these
options and alternatives is assessed based on its likeli-
hood of achieving success, time to success, and cost.
Ultimately, this analysis recommends that the Focused
Ultrasound Foundation take no statutory action to
reclassify FUS at this time, and initiate efforts to
increase Foundation stakeholder understanding of FDA
regulations and their impact on the future of FUS.
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